Breaking News

Tuesday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ATRS

Antares Pharma

$2.28

-0.01 (-0.44%)

07:11
01/16/18
01/16
07:11
01/16/18
07:11
Hot Stocks
Antares announces Type A meeting scheduled with FDA on Feb. 21 for XYOSTED »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Feb

Over a week ago
ATRS

Antares Pharma

$2.02

0.01 (0.50%)

16:06
12/21/17
12/21
16:06
12/21/17
16:06
Hot Stocks
Antares Pharma provides regulatory update for Xyosted »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAG

Amag Pharmaceuticals

$13.85

-0.35 (-2.46%)

, ATRS

Antares Pharma

$1.99

-0.03 (-1.49%)

08:03
12/20/17
12/20
08:03
12/20/17
08:03
Hot Stocks
Amag Pharmaceuticals issued new patent for Makena birth treatment »

AMAG Pharmaceuticals…

AMAG

Amag Pharmaceuticals

$13.85

-0.35 (-2.46%)

ATRS

Antares Pharma

$1.99

-0.03 (-1.49%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

  • 14

    Feb

Over a month ago
ATRS

Antares Pharma

$1.89

0.01 (0.53%)

07:11
11/07/17
11/07
07:11
11/07/17
07:11
Earnings
Antares Pharma reports Q3 EPS (3c), consensus (3c) »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Nov

  • 15

    Nov

  • 28

    Nov

AMAG

Amag Pharmaceuticals

$15.60

-0.45 (-2.80%)

, ATRS

Antares Pharma

$2.18

0.06 (2.83%)

09:29
10/23/17
10/23
09:29
10/23/17
09:29
Recommendations
Amag Pharmaceuticals, Antares Pharma analyst commentary at Janney Capital »

Antares CRL doesn't…

AMAG

Amag Pharmaceuticals

$15.60

-0.45 (-2.80%)

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 02

    Feb

  • 14

    Feb

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

09:02
10/23/17
10/23
09:02
10/23/17
09:02
Recommendations
Antares Pharma analyst commentary at Raymond James »

Antares Pharma maintained…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMAG

Amag Pharmaceuticals

$15.60

-0.45 (-2.80%)

, ATRS

Antares Pharma

$2.18

0.06 (2.83%)

08:56
10/23/17
10/23
08:56
10/23/17
08:56
Recommendations
Amag Pharmaceuticals, Antares Pharma analyst commentary at Morgan Stanley »

Antares CRL should have…

AMAG

Amag Pharmaceuticals

$15.60

-0.45 (-2.80%)

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

  • 02

    Feb

  • 14

    Feb

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

06:09
10/23/17
10/23
06:09
10/23/17
06:09
Recommendations
Antares Pharma analyst commentary at Piper Jaffray »

Antares shares 'can…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATRS

Antares Pharma

$2.18

0.06 (2.83%)

18:59
10/20/17
10/20
18:59
10/20/17
18:59
Hot Stocks
FDA cannot approve Antares Pharma's Xyosted NDA »

Antares Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

ATRS

Antares Pharma

$2.12

-0.11 (-4.93%)

07:22
10/20/17
10/20
07:22
10/20/17
07:22
Conference/Events
Breaking Conference/Events news story on Antares Pharma »

FDA PDUFA Date for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.